Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?

被引：5

作者：

Feng, Rui ^{[1
,2
]}

Zhang, Zhenlu ^{[1
]}

Fan, Qingkun ^{[1
]}

机构：

[1] Wuhan Univ Sci & Technol, Dept Lab Med, Wuhan Asian Heart Hosp, Wuhan, Peoples R China

[2] Wuhan Univ Sci & Technol, Sch Med, Wuhan, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 13卷

关键词：

carbohydrate antigen 125; congestive heart failure; heart failure; N-terminal Pro-B-type natriuretic peptide; tissue congestion; BRAIN NATRIURETIC PEPTIDE; OVARIAN-CANCER ANTIGEN; SERUM CA-125 LEVELS; TUMOR-MARKERS; INFLAMMATORY ACTIVATION; VENTRICULAR-FUNCTION; ATRIAL-FIBRILLATION; PROGNOSTIC VALUE; AORTIC-STENOSIS; RISK PREDICTION;

D O I：

10.3389/fonc.2023.1161723

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Congestion is the permanent mechanism driving disease progression in patients with acute heart failure (AHF) and also is an important treatment target. However, distinguishing between the two different phenotypes (intravascular congestion and tissue congestion) for personalized treatment remains challenging. Historically, carbohydrate antigen 125 (CA125) has been a frequently used biomarker for the screening, diagnosis, and prognosis of ovarian cancer. Interestingly, CA125 is highly sensitive to tissue congestion and shows potential for clinical monitoring and optimal treatment of congestive heart failure (HF). Furthermore, in terms of right heart function parameters, CA125 levels are more advantageous than other biomarkers of HF. CA125 is expected to become a new biological alternative marker for congestive HF and thereby is expected be widely used in clinical practice.

引用

页数：14

共 113 条

[11] Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
Colombo, Paolo C.
Ganda, Anjali
Lin, Jeffrey
Onat, Duygu
Harxhi, Ante
Iyasere, Julia E.
Uriel, Nir
Cotter, Gad
[J]. HEART FAILURE REVIEWS, 2012, 17 (02) : 177 - 190
[12] Verdict In Congestion Guilty
Costanzo, Maria Rosa
[J]. JACC-HEART FAILURE, 2015, 3 (10) : 762 - 764
[13] Serum levels of carbohydrate antigen 125 in patients with chronic heart failure - Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis
D'Aloia, A
Faggiano, P
Aurigemma, G
Bontempi, L
Ruggeri, G
Metra, M
Nodari, S
Dei Cas, L
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) : 1805 - 1811
[14] Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation
De Gennaro, Luisa
Brunetti, Natale Daniele
Montrone, Deodata
De Rosa, Fiorella
Cuculo, Andrea
Di Biase, Matteo
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (04) : 371 - 375
[15] Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation
den Uijl, Dennis W.
Delgado, Victoria
Bertini, Matteo
Tops, Laurens F.
Trines, Serge A.
van de Veire, Nico R.
Zeppenfeld, Katja
Schalij, Martin J.
Bax, Jeroen J.
[J]. HEART, 2011, 97 (22) : 1847 - 1851
[16] Cancer antigen 125 in patients with chronic liver disease
Devarbhavi, H
Kaese, D
Williams, AW
Rakela, J
Klee, GG
Kamath, PS
[J]. MAYO CLINIC PROCEEDINGS, 2002, 77 (06) : 538 - 541
[17] Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
Dochez, Vincent
Caillon, Helene
Vaucel, Edouard
Dimet, Jerome
Winer, Norbert
Ducarme, Guillaume
[J]. JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
[18] Elevated serum CA 125 levels in mitral stenotic patients with heart failure
Duman, C
Ercan, E
Tengiz, I
Bozdemir, H
Ercan, HE
Nalbantgil, I
[J]. CARDIOLOGY, 2003, 100 (01) : 7 - 10
[19] Serum carbohydrate antigen 125 levels in advanced heart failure: Relation to B-type natriuretic peptide and left atrial volume
Duman, Dursun
Palit, Fatih
Simsek, Ergun
Bilgehan, Karadag
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (06) : 556 - 559
[20] Durak-Nalbantic Azra, 2013, Med Arch, V67, P241

← 1 2 3 4 5 6 7 8 9 10 →